# Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children

> **NCT00950833** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 466 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** Pneumococcal vaccine GSK1024850A

## Key facts

- **NCT ID:** NCT00950833
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-10
- **Primary completion:** 2010-09-16
- **Final completion:** 2010-10-27
- **Target enrollment:** 466 (ACTUAL)
- **Last updated:** 2018-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00950833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00950833, "Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00950833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*